In a validation cohort, the levels of eight peptides derived from NFL, MAP1B, MYL1, APOC1, CADM3, SCG1, and PENK proteins changed in ALS compared to controls. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.